Ibrahim Halawani

Ibrahim Halawani

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
HNHouriah Y Nukaly
Houriah Y Nukaly
IHIbrahim Halawani
Ibrahim Halawani
SASaja Mohammed S. Alghamdi
Saja Mohammed S. Alghamdi
AAAraa Ghanem Alruwaili
Araa Ghanem Alruwaili
ABAlhanouf Khalid Binhezaim
Alhanouf Khalid Binhezaim
Abdulhadi JfriAbdulhadi Jfri
Abdulhadi Jfri
Background/Objectives: Oral Lichen Planus (OLP) is a common immune-mediated inflammatory disorder affecting the oral mucosa, impacting 0.5% to 2% of the global population, primarily middle-aged women. Immunological dysregulation is a key factor in OLP’s pathogenesis, involving CD4+ T helper and CD8+ T cytotoxic cells. The World Health Organization (WHO) classifies OLP as a potentially malignant disorder, with a risk of oral squamous cell carcinoma (OSCC) developing in up to 2% of lesions. This narrative review aims to provide a comprehensive overview of the etiopathogenesis, clinical manifestations, diagnostic criteria, and therapeutic strategies for OLP, informing clinical practice and guiding future research. Methods: A review of the literature from the PubMed and Google Scholar databases was conducted up to December 2023, focusing on studies addressing the etiopathogenesis, diagnosis, clinical manifestations, and treatment of OLP. Results: OLP’s pathogenesis is driven by immune dysregulation, with CD4+ and CD8+ cells playing crucial roles. Clinically, OLP presents as reticular, erosive, bullous, and plaque-like lesions. Diagnosis relies on clinical examination, histopathology, and direct immunofluorescence. Recent advancements in diagnostic markers and imaging techniques have improved detection and monitoring. Treatment primarily involves corticosteroids, but novel therapies such as curcumin, retinoids, and laser therapy are increasingly used for their effectiveness and reduced side effects. These treatments show promise in symptom reduction and recurrence prevention, although long-term data are needed. Conclusions: Regular screenings and biopsies are essential due to OLP’s likelihood of malignant transformation. This study urges further investigation into long-term results, improved diagnostic techniques, and evidence-based treatment regimens.

8 June 2023 in JPRAS Open
Verified
Journal Article
Open access
HMHatan Mortada
Hatan Mortada
NANajla Alkilani
Najla Alkilani
IHIbrahim Halawani
Ibrahim Halawani
WZWasan Al Zaid
Wasan Al Zaid
RARema Sultan Alkahtani
Rema Sultan Alkahtani
ONOmar Fouda Neel
Omar Fouda Neel
Facelift procedures are a popular method of facial rejuvenation. The most common technique is superficial muscular aponeurotic system (SMAS) plication, with several variations. However, the optimal approach remains unclear. This review analyzed previous studies to compare SMAS facelift techniques, their outcomes, and complication rates. A systematic search was conducted using the MEDLINE, Cochrane, Embase, and Google Scholar electronic databases in September 2022. The search included studies published from January 2000 to September 2022 using keywords such as “facelift,” “complications,” and “outcomes.” This review examined 27 selected studies that evaluated 6 SMAS facelift techniques. The studies involved 6086 patients in total, over 85% of who were satisfied with the outcome of their surgery. The complication rates varied depending on the technique used, with the SMAS flap and composite SMAS technique having the highest (5.75%) and lowest (0.05%) complication rates, respectively. The most common complications were temporary facial nerve injury (0.85%) and skin necrosis (0.41%). To date, only one case of permanent facial nerve injury has been reported. On the basis of our findings, SMAS facelift techniques achieve high patient satisfaction rates, with complication rates that vary by technique. The composite SMAS technique showed the lowest complication rates, whereas the SMAS flap showed the highest rate. However, some studies have not reported all complications, making it difficult to determine the best approach. Therefore, future studies are required to identify the most aesthetically pleasing technique with the lowest complication risk.

18 November 2024 in Aesthetic Plastic Surgery
Verified
Journal Article
Closed access
PDF file
AAAbdulaziz Abumelha
Abdulaziz Abumelha
IHIbrahim Halawani
Ibrahim Halawani
RARakan Abu Alqam
Rakan Abu Alqam
FAFeryal Khalid Alali
Feryal Khalid Alali
RARazan Omar Alsubhi
Razan Omar Alsubhi
NANawaf Alohaideb
Nawaf Alohaideb

21 December 2023 in Aesthetic Plastic Surgery
Verified
Journal Article
Closed access
PDF file
AAAbdulmalek Alhithlool
Abdulmalek Alhithlool
AQAbdullah Abdulhadi Al Qurashi
Abdullah Abdulhadi Al Qurashi
IHIbrahim Halawani
Ibrahim Halawani
SASarah Wadea Alkhonizy
Sarah Wadea Alkhonizy
NANouf Z. AlBattal
Nouf Z. AlBattal
HMHatan Mortada
Hatan Mortada

11 July 2024 in Aesthetic Plastic Surgery
Verified
Journal Article
Closed access
PDF file
AAAbdulaziz Alabdulkarim
Abdulaziz Alabdulkarim
IAIbrahim Abdullah S. Albalawi
Ibrahim Abdullah S. Albalawi
AQAbdullah Abdulhadi Al Qurashi
Abdullah Abdulhadi Al Qurashi
IHIbrahim Halawani
Ibrahim Halawani
JNJumanah Y. Nassar
Jumanah Y. Nassar
AAAsim M. Albishry
Asim M. Albishry

18 December 2023 in Children
Verified
Journal Article
Open access
PDF file
MBMohammed Sulaiman Bhader
Mohammed Sulaiman Bhader
MAMohammed Y Y Al-Hindi
Mohammed Y Y Al-Hindi
AGAbdullah Ghaddaf
Abdullah Ghaddaf
AAAnas Alamoudi
Anas Alamoudi
AAAmal Abualola
Amal Abualola
MAMansour Al-Qurashi
Mansour Al-Qurashi
The noninvasive neurally adjusted ventilatory assist (NIV-NAVA) is a newly developed noninvasive ventilation technique with promising clinical and ventilatory outcomes for preterm infants. This systematic review and meta-analysis aimed to investigate whether NIV-NAVA has better clinical and ventilatory outcomes than nasal continuous airway pressure (NCPAP) or noninvasive positive pressure ventilation (NIPP) on premature infants. MEDLINE, Embase, and CENTRAL were searched, and randomized controlled trials (RCTs) that compared NIV-NAVA with NCPAP or NIPP for preterm infants (gestational age: <37 weeks) were included. We evaluated the following outcomes in the neonatal intensive care unit: the desaturation rate, failure of noninvasive modality requiring intubation when received as the primary mode or the need for re-intubation after extubation from mechanical ventilation in the secondary mode (weaning), length of stay, and fraction of inspired oxygen. The mean difference and risk ratio were used to represent continuous and dichotomous outcomes, respectively. We included nine RCTs involving 339 preterm infants overall. NIV-NAVA showed similar clinical and ventilatory outcomes to NCPAP or NIPP, except for the maximum diaphragmatic electrical activity. The rate of failure of the noninvasive modality was not statistically different between NIV-NAVA and NCPAP. The pooled estimates for the maximum electrical activity were significantly reduced in NIV-NAVA compared with those in NIPP. The findings suggest that NIV-NAVA may be as safe and effective as NCPAP and NIPP for preterm neonates, particularly those who may not tolerate these alternative noninvasive methods. However, further trials are recommended for greater evidence.